Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas J. Herzog, MD
Herbert Irving Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia, United States
- Mbccop - Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Advocate Lutheran General Cancer Care Center
Park Ridge, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Woman'S Hospital
Baton Rouge, Louisiana, United States
- Union Hospital Cancer Program at Union Hospital
Elkton, Maryland, United States
- Tufts-Nemc Cancer Center
Boston, Massachusetts, United States
- Umass Memorial Cancer Center - University Campus
Worcester, Massachusetts, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
- Genesys Hurley Cancer Institute
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
- Foote Memorial Hospital
Jackson, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Sparrow Regional Cancer Center
Lansing, Michigan, United States
- St. Mary Mercy Hospital
Livonia, Michigan, United States
- St. Joseph Mercy Oakland
Pontiac, Michigan, United States
- Mercy Regional Cancer Center at Mercy Hospital
Port Huron, Michigan, United States
- William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
- Seton Cancer Institute at Saint Mary'S - Saginaw
Saginaw, Michigan, United States
- St. John Macomb Hospital
Warren, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2005
- Primary completion
- 31 Jan 2011
- Completion
- —
- Last update posted
- 24 Jul 2018
- Registered enrollment
- 81
- Registry id
- NCT00114166
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.